PhRMA chief resigns amid Trump drug-pricing clash

TL;DR Summary
Steve Ubl, PhRMA’s CEO, will step down after steering the drug industry toward a tougher lobbying stance as Washington and President Trump spar over drug prices, including threats of tariffs; a successor will be named as the pricing fight continues.
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
19 min
vs 20 min read
Condensed
99%
3,857 → 40 words
Want the full story? Read the original article
Read on The Washington Post